Epidemiological research of portopulmonary hypertension in patients with liver cirrhosis

Epidemiological research of portopulmonary hypertension in patients with liver cirrhosis - Epidemiological research of portopulmonary hypertension in patients with liver cirrhosis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040426

Enrollment

1000

Registered

2020-05-18

Start date

2020-05-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as liver cirrhosis based on the results of imaging modality (abdominal CT or ultrasonography) or proven by liver biopsy.

Exclusion criteria

Exclusion criteria: 1. Patients with uncontrollable hepatocellular carcinoma, 2. Patients with chronic respiratory disease, 3. Patients with left ventricular heart disease, 4. Patients with chronic pulmonary embolism, 5. Patients with blood disease, 6. Patients with sarcoidosis 7. Patients with thyroid disease, 8. Patients with connective tissue disease, 9. Patients with Human Immunodeficiency Virus infection, 10. Patients with congenital heart disease

Design outcomes

Primary

Measure	Time frame
Diagnostic method and accuracy to diagnose portopulmonary hypertension in patients with liver cirrhosis	—

Countries

Japan

Contacts

Public ContactMasanori Atsukawa

Nippon Medical School Division of Gastroenterology and Hepatology

momogachi@yahoo.co.jp03-3822-2131

Outcome results